23
Views
16
CrossRef citations to date
0
Altmetric
Article

Novel radioprotectant drugs for sparing radiation‐induced damage to the physis

, , , , &
Pages 217-228 | Received 17 Feb 2003, Accepted 28 Jan 2004, Published online: 03 Jul 2009

References

  • AYGENC, E., CELIKKANAT, S., BILGILI, H., AKSARAY, F., ORHUN, S., KAympd(ci, M. and OZDEM, C., 2001, Pentoxifylline effects on acute and late complications after radiotherapy in rabbit. Otolaryngology and Head and Neck Surgery, 124, 669–673.
  • BIANCO, J., APPELBAUM, F., NEMUNAITIS, J., ALMGREN, J., ANDREWS, F., KETINER, P., SHIELDS, A. and SINGER, J., 1991, Phase I—II trial of pentoxifylline for the prevention of transplant related toxicities following bone marrow transplantation. Blood, 78, 1205–1211.
  • CHIJA, D., Lo, C., Yu, J. and Foo, Y., 2001, A pilot study of pentoxifylline in the treatment of radiation-induced trismus. American Journal of Clinical Oncology, 24, 366–369.
  • CRUZ-OluvE, L. M., 1980, On the estimation of particle number. Journal of Microscopy, 120, 15–27.
  • DAMRON, T. A., SPADARO, J. A., TAMBRIAN, R. M. and DAMRON, L. A., 2000, Sparing of radiation-induced damage to the physis: fractionation alone compared to amifostine pretreatment. International Journal of Radiation Oncology, Biology, Physics, 47, 1067–1071.
  • DAMRON, T. A., MARGUILES, B., STRAUSS, J., SPADARD, J. and FARNUM, C. E., 2003, Sequential histomorphometric changes following irradiation of the growth plate with and without radioprotectant. Journal of Bone and Joint Surgery, 85, 1302–1313.
  • DEL TORO, F. J., SYLVIA, V., SCHUBKEGEL, S., CAMPOS, R., DEAN, D., BOYAN, B. and SCHWARTZ, Z., 2000, Characterization of prostaglandin E2 receptors and their role in 24,25-(OH)2D3-mediated effects on resting zone chond.rocytes. Journal of Cellular Physiology, 182, 196–208.
  • DION, M., HUSSEY, D., DOORNBOS, J., ViGuoTri, A., WEN, B. and ANDERSON, B., 1990, Preliminary results of a pilot study of pentoxifylline in the treatment of late radiation soft tissue necrosis. International Journal of Radiation Oncology, Biology, Physics, 19, 401–407.
  • EIFEL, P. J., 1988, Decreased bone growth arrest in weanling rats with multiple radiation fractions per day. International Journal of Radiation Oncology, Biology, Physics, 15, 141–145.
  • EIFEL, P. J., SAMPSON, C. M. and TUCKER, S. L., 1990, Radiation fractionation sensitivity of epiphyseal cartilage in a weanling rat model. International Journal of Radiation Oncology, Biology, Physics, 19, 661–664.
  • GRUMBLES, R., SAO, L., JEFFREY, J. J. and HOWELL, D. S., 1997, Regulation of the rat interstitial collagenase promoter by IL-1 beta, c-Jun, and Ras-dependent signaling in growth plate chondrocytes. Journal of Cellular Biochemistry, 67, 92–102.
  • HANSON, W., 1987, Radioprotection of murine intestine by WR-2721, 16,16 climethyl prostaglandin E[-2j and the combination of both agents. Radiation Research, 111, 361–373.
  • HANSON, W., 1997, Eicosanoid-induced raclioprotection and chemoprotection: laboratory studies and clinical applications. In E. Bump and K. Malaker (eds), Radioprotectors: Chemical, Biological, and Clinical Perspectives (New York: CRC Press), pp. 197–212.
  • HANSON, W., ZHEN, W., GENG, L., HUNTER, N. and MrtAs, L., 1995, The prostaglandin El analog, misoprostol, a normal tissue protector, does not protect four murine tumors in vivo from radiation injury. Radiation Research, 142, 281–287.
  • HORAN, J., DEAN, D. D., KrEswErrER, K., SCHWARTZ, Z. and BOYAN, B. D., 1996, Evidence that interleukin-1, but not interleukin-6, affects costochond.ral chond.rocyte proliferation, differentiation, and matrix synthesis through an autocrine pathway. Journal of Bone and Mineral Research, 11, 1119–1129.
  • HORIUCHI, H., SAITO, N., KINOSHITA, T., WAKABAYASHI, S., TSUTSUMIMOTO, T. and TAKAOKA, K., 2001, Enhancement of bone morphogenetic protein-2-induced new bone formation in mice by the phosphocliesterase inhibitor pentoxifylline. Bone, 28, 290–294.
  • IWAMOTO, M., KOIKE, T., NAKASHIMA, K., SATO, K. and KATO, Y., 1989, Interleukin 1: a regulator of chond.rocyte proliferation. Immunology Letters, 21, 153–156.
  • KAWASHIMA-OHYA, Y., SATAKEDA, H., KURUTA, Y., KAWAMOTO, T., YAN, W., AKAGAWA, Y., HAYAKAWA, T., NOSHERO, M., OKADA, Y., NAKAMURA, S. and KATO, Y., 1998, Effects of parathyroid hormone (PTH) and PTH-related peptide on expressions of matrix metalloproteinase-2, -3, and -9 in growth plate chondrocyte cultures. Endocrinology, 139, 2120–2127.
  • KINUYA, S., YOKOYAMA, K., KONISHI, S., Li, X., WATANABE, N., SnuxE, N., TAKAYAMA, T., BUNKO, H., MicmGism, T. and
  • TONAMI, N., 2001, Improved response of colon cancer xenografts to radioimmunotherapy with pentoxifylline treatment. European Journal of Nucleic Medicine, 28, 750–755.
  • KOH, W.-J., STELZER, K., PETERSON, L., STAKER, B., WARD, W., RUSSET.', K. and GRIFFIN, T., 1995, Effect of pentoxifylline on radiation-induced lung and skin toxicity in rats. International Journal of Radiation Oncology, Biology, Physics, 31, 71–77.
  • LEE, T. K. and STUPANS, I., 2002, Radioprotection: the non-steroidal anti-inflammatory drugs (NSAIDs) and prostaglanclins. Journal of Pharmaceutics and Pharmacology, 54, 1435–1445.
  • MOLTEN', A., MOULDER, J., COHEN, E., WARD, W., FISH, B., TAYLOR, J., WOLFE, L., BRIZIO-MOLTENI, L. and VENO, P., 2000, Control of radiation-induced pneumopathy and lung fibrosis by angiotensin-converting enzyme inhibitors and an angiotensin II type 1 receptor blocker. International Journal of Radiation Biology, 76, 523–532.
  • MUTLU-TURKOGLU, U., ERBIL, Y., OZTEZCAN, S., OLGAC, V., TOKER, G. and UYSAL, M., 2000, The effect of selenium and/ or vitamin E treatments on radiation-induced intestinal injury in rats. Life Sciences, 66, 1905–1913.
  • NETA, R., VOGEL, S., SIPE, J., WONG, G. and NORDAN, R., 1988, Comparison of in vivo effects of human recombinant IL 1 and human recombinant IL 6 in mice. Lymphokine Research, 7, 403–412.
  • NIELSEN, B. S., LUND, L. R., CHRISTENSEN, I. J., JOHNSEN, M., USHER, P. A., WULF-ANDERSEN, L., FRANDSEN, T. L., DANO, K. and GUNDERSEN, H. J., 2001, A precise and efficient stereological method for determining murine lung metastasis volumes. American Journal of Pathology, 158, 1997–2003.
  • OKUNIEFF, P., Li, M., Liu, W., SUN, J., FENTON, B., ZHANG, L. and DING, I., 2001, Keratinocyte growth factors radioprotect bowel and bone marrow but not KHT sarcoma. American Journal of Clinical Oncology, 24, 491–495.
  • OKUNIEFF, P., MESTER, M., WANG, J., MADDOX, T., GONG, X., TANG, D., COFFEE, M. and DING, I., 1998, In vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice. Radiation Research, 150, 204–211.
  • PATCHEN, M., 1997, Immunomodulators and cytokines: their use in the mitigation of radiation-induced hemopoietic injury. In E. Bump and K. Malaker (eds), Radioprotectors: Chemical, Biological, and Clinical Perspectives (New York: CRC Press), pp. 213–236.
  • PATEDER, D. B., SHEU, T. J., O'KEEFE, R. J., PuzAs, J. E., SCHWARZ, E. M., CONSTINE, L. S., OKUNIEFF, P. and ROSIER, R. N., 2002, Role of pentoxifylline in preventing radiation damage to epiphyseal growth plate chond.rocytes. Radiation Research, 157, 62–68.
  • SANKARANARAYANAN, K., VAN DUYN-GOEDHART, A., DERoou, D. G. and VAN BUUL, P. P. W., 1995, Raclioprotective effects of prostaglanclins in V-79 Chinese hamster cells grown as spheroids in vitro and in mouse spermatogonial stem cells and bone marrow cells in vivo. International Journal of Radiation Biology, 67, 47–55.
  • STEEL, L. and LEDNEY, G., 1987, Effects of neutron irradiation of PGE2 and T x B2 levels in biological fluids: modification by VVR-2721. In T. Walden and H. Hughes (eds), Prostaglandins and LOid Metabolism in Radiation Injury (New York: Plenum), pp. 207–218.
  • STEET, L., WALDEN, T. L., JR, HUGHES, H. N. and JAcKsoN, W. E. III., 1988, Protection of mice against mixed fission neutron-gamma (n:gamma =1:1) irradiation by VVR-2721, STEM 16,16-dimethyl PGE2, and the combination of both agents. Radiation Research, 115, 605–608.
  • STELZER, K., KOH, W., KURTZ, H., GREER, B. and GRIFFIN, T., 1994, Caffeine consumption is associated with decreased severe late toxicity after radiation to the pelvis. International Journal of Radiation Oncology, Biology, Physics, 30, 411–417.
  • TAMURIAN, R. M., DAMRON, T. A. and SPADARO, J. A., 1999, Sparing radiation-induced damage to the physis by raclioprotectant drugs: laboratory analysis in a rat model. Journal of Orthopaedic Research, 17, 286–292.
  • WANG, X., DING, I., Xis, H., Wu, T., WERSTO, N., HUANG, K. and OKUNIEFF, P., 1998, Hyperbaric oxygen and basic fibroblastic growth factor promote growth of irradiated bone. International Journal of Radiation Oncology, Biology, Physics, 40, 189–196.
  • WEISS, J., HOOVER, R. and KUMAR, K., 1987, Selenium pretreatment enhances the raclioprotective effect and reduces the lethal toxicity of WR-2721. Free Radical Research Communications, 3, 33–38.
  • WEISS, J., SRINIVASAN, V., KUMAR, K. and LANDAUER, M., 1992, Raclioprotection by metals: selenium. Advances in Space Research, 12, 223–231.
  • WERNER-WASIK, M. and MADOC-JONES, H., 1993, Trental (pentoxifylline) relieves pain from postradiation fibrosis (letter). International Journal of Radiation Oncology, Biology, Physics, 25, 757–758.
  • WLSMAN, N. J., FARNIJM, C. E., LEIFERMAN, E. M., FRY, M. and BARRET°, C., 1996, Differential growth by growth plates as a function of multiple parameters of chondrocytic kinetics. Journal of Orthopaedic Research, 14, 927–936.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.